Skip to content
Recall Observatory FDA recall evidence

Drug product

Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13

D-0469-2024

April 09, 2024

Class III

Product summary

Firm
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Event
Event 94382
Status
Ongoing
Classification
Class III
Quantity
N/A
Official record key
drug-enforcement:D-0469-2024

Official wording

Reason: Cross Contamination with Other Products

Code information: Lot # APS00423A, Exp 07/31/2025; APS00222A, Exp 11/30/2024

Distribution pattern: USA nationwide.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Cross Contamination with Other Products